Neuland Labs commissions first module at commercial peptide plant
Foundational infrastructure for a second module is already in place, and the company says work could start ahead of the original timeline.
The wire
- 01Neuland Laboratories said the first of four planned modules at its commercial peptide manufacturing site is now operational.
- 02Peptide API capacity additions matter to buyers tracking supply for approved peptide drugs and contract manufacturing constraints.
- 03Timing for the second module depends on customer requirements being finalised; the company gave no capacity or contract figures, and the stock saw profit booking.
From the source
Read at cnbctv18.comNeuland Labs' first commercial peptide manufacturing module goes operational; Stock sees profit booking
Neuland Laboratories said the facility is one of four scheduled modules at its commercial peptide manufacturing site. With the foundational infrastructure for the second module already in place, Neuland expects to begin work ahead of the original timeline once customer requirements are finalised.